Form 8-K bluebird bio, Inc. For: Nov 04

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. SBUX
9. SNDK
10. MA

Go back to Form 8-K bluebird bio, Inc. For: Nov 04

bluebird bio (BLUE) Post-ASH Abstract Sell-Off an 'Overreaction', Oppenheimer Says

November 5, 2015 11:00 AM EST

Oppenheimer analyst Wendy Lam weighed in on bluebird bio (NASDAQ: BLUE), saying the Post-ASH abstract sell-off is overdone.

Lam commented, "BLUE published six ASH abstracts this morning, three of which were focused on LentiGlobin in beta-thalassemia and sickle cell disease. Key updates disclosed in the abstracts include new data from additional patients treated in the Northstar and HBG-205... More

bluebird bio (BLUE) Posts Wider-than-Expected Q3 Loss

November 5, 2015 6:45 AM EST

bluebird bio (NASDAQ: BLUE) reported Q3 EPS of ($1.18), $0.24 worse than the analyst estimate of ($0.94). Revenue for the quarter came in at $1.32 million versus the consensus estimate of $5.2 million.

Cash, cash equivalents and marketable securities as of September 30, 2015 were $901.7 million, compared to $492.0 million as of... More